Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Plan-sponsor savings and member experience with point-of-service prescription step therapy.

Motheral BR, Henderson R, Cox ER.

Am J Manag Care. 2004 Jul;10(7 Pt 1):457-64.

2.

Health plan member experience with point-of-service prescription step therapy.

Cox ER, Henderson R, Motheral BR.

J Manag Care Pharm. 2004 Jul-Aug;10(4):291-8.

4.

A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.

Clark BE, Siracuse MV, Garis RI.

Res Social Adm Pharm. 2009 Jun;5(2):133-42. doi: 10.1016/j.sapharm.2008.06.002. Epub 2009 Jan 31.

PMID:
19524861
6.
7.

Controlling prescription drug expenditures: a report of success.

Miller DP, Furberg CD, Small RH, Millman FM, Ambrosius WT, Harshbarger JS, Ohl CA.

Am J Manag Care. 2007 Aug;13(8):473-80.

8.

Effects on the cost and utilization of proton pump inhibitors from adding over-the counter omeprazole to drug benefit coverage in a state employee health plan.

Harris BN, West DS, Johnson J, Hong SH, Stowe CD.

J Manag Care Pharm. 2004 Sep-Oct;10(5):449-55. Erratum in: J Manag Care Pharm. 2005 Jan-Feb;11(1):87.

10.

Implications of an SSRI generic step therapy pharmacy benefit design: an economic model in anxiety disorders.

Panzer PE, Regan TS, Chiao E, Sarnes MW.

Am J Manag Care. 2005 Oct;11(12 Suppl):S370-9.

11.

Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000.

Haas JS, Phillips KA, Gerstenberger EP, Seger AC.

Ann Intern Med. 2005 Jun 7;142(11):891-7.

PMID:
15941695
12.

Undocumented source of pharmacy benefit manager revenue.

Siracuse MV, Clark BE, Garis RI.

Am J Health Syst Pharm. 2008 Mar 15;65(6):552-7. doi: 10.2146/ajhp070389.

PMID:
18319501
13.

Mitigation of medication mishaps via medication therapy management.

Pindolia VK, Stebelsky L, Romain TM, Luoma L, Nowak SN, Gillanders F.

Ann Pharmacother. 2009 Apr;43(4):611-20. doi: 10.1345/aph.1L591. Epub 2009 Mar 31.

PMID:
19336646
14.
15.
16.

Impact of patient and plan design factors on switching to preferred statin therapy.

Cox ER, Kulkarni A, Henderson R.

Ann Pharmacother. 2007 Dec;41(12):1946-53. Epub 2007 Oct 30.

PMID:
17971409
17.
18.

Consumer attitudes and factors related to prescription switching decisions in multitier copayment drug benefit plans.

Ganther-Urmie JM, Nair KV, Valuck R, McCollum M, Lewis SJ, Turpin RS.

Am J Manag Care. 2004 Mar;10(3):201-8.

19.

Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit.

Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW.

Am J Manag Care. 2009 Dec;15(12):881-8.

20.

Supplemental Content

Support Center